2018, Number 2
Alerg Asma Inmunol Pediatr 2018; 27 (2)
Saucedo AAG, Espinosa PSE, González SME, Medina TEA
PDF size: 174.08 Kb.
ABSTRACTBackground: SCID is part of the PID group and it’s considered the most severe and rare, which leads to SCID be likely underestimated or underdiagnosed. Objective: To know the current situation in Mexico regarding the report of new cases with diagnosis of SCID. Material and methods: The reported for five years in SAEH of SCID patients was searched electronically to compare it with LASID Mexico in the same period of time. In order to know which of the two registers came closest to the number of new cases diagnosed in a year, we chose to collect all the cases referred with SCID to the CNR-IDP, for almost a year. Results: We found that the cases of SCID reported by LASID are tripled compared to the SAEH reports. Regarding the patients referred to the CNR-IDP, it was established that the number of cases was closer to the reports per year of LASID, establishing a diagnostic delay of 5.5 months on average. Conclusion: The incidence of SCID in México is affected by underdiagnosed and underreporting of the disease.